OTC Stocks Trading Higher: MFTH, ACTC, AEGY, ADXS

Pompano Beach, FL -- (SBWIRE) -- 01/14/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

Medisafe 1 Technologies Corp (OTC:MFTH) is currently trading at $0.0031, 82.35% higher. Develops medical assemblies and protectors. The Company develops medications for medical errors and drug related injury.

Can MFTH Continue To Move Higher? Find Out Here

Advanced Cell Technology, Inc. (OTC:ACTC) is higher 5.91% to $0.0860. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.

Can ACTC Extend Rally? Find Out Here

Alternative Energy Partners Inc (OTC:AEGY) added 28.57% to $0.0009. Alternative Energy Partners, Inc. (AEGY) is a development-stage company. The Company was formed for the purpose of establishing a renewable fuel sources initially within the State of Florida. Ethanol was the Company’s initial intended product and it intends to establish other alternative energy products and services including, but not limited to, solar-thermal energy production, energy management controls, and more.

How Should Investors Trade AEGY Now? Find Out Here

Advaxis, Inc. (OTC:ADXS) among the gainers and the stock added 3.09% to $0.0701. Advaxis, Inc. (Advaxis) is a development-stage company. The Company is a biotechnology company with the focus to develop immunotherapies for cancer and infectious diseases. These immunotherapies are based on a platform technology under license from the University of Pennsylvania (Penn), which utilizes live attenuated Listeria monocytogenes (Listeria or Lm) , bioengineered to secrete antigen/adjuvant fusion proteins.

How Should Investors React To ADXS Now? Find Out Here

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com